Perrigo explores sale of royalties of drug Tysabri: sources
Go back to Perrigo explores sale of royalties of drug Tysabri: sources| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 190.52 -1.64 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $192.16 | 52 Week High | $333.65 | |||
| Open | $191.75 | 52 Week Low | $223.02 | |||
| Day High | $192.56 | P/E | 24.39 | |||
| Day Low | $189.52 | EPS | $7.81 | |||
| Volume | 1,512,006 | |||||
| Mylan Inc. (NASDAQ: MYL) | Delayed: 15.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.86 | 52 Week High | $55.51 | |||
| Open | $10.56 | 52 Week Low | $33.60 | |||
| Day High | $15.86 | P/E | 10.43 | |||
| Day Low | $15.86 | EPS | $1.52 | |||
| Volume | 45,581 | |||||
| Perrigo (NYSE: PRGO) | Delayed: 29.94 -0.1 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.04 | 52 Week High | $156.03 | |||
| Open | $29.99 | 52 Week Low | $79.72 | |||
| Day High | $30.12 | P/E | N/A | |||
| Day Low | $29.83 | EPS | $0.00 | |||
| Volume | 971,548 | |||||
